BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 25001061)

  • 21. [The diagnostic significance of single or combination lung cancer-related serum biomarkers in high risk lung cancer patients].
    Ni J; Guo Z; Zhang L
    Zhonghua Nei Ke Za Zhi; 2016 Jan; 55(1):25-30. PubMed ID: 26796649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative Cyfra21-1 and SCC-Ag serum titers predict survival in patients with stage II esophageal squamous cell carcinoma.
    Cao X; Zhang L; Feng GR; Yang J; Wang RY; Li J; Zheng XM; Han YJ
    J Transl Med; 2012 Sep; 10():197. PubMed ID: 22999061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer.
    Markovina S; Wang S; Henke LE; Luke CJ; Pak SC; DeWees T; Pfeifer JD; Schwarz JK; Liu W; Chen S; Mutch D; Wang X; Powell MA; Siegel BA; Dehdashti F; Silverman GA; Grigsby PW
    Br J Cancer; 2018 Jan; 118(1):72-78. PubMed ID: 29112685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma microRNA-19a as a potential biomarker for esophageal squamous cell carcinoma diagnosis and prognosis.
    Bai Y; Lin H; Fang Z; Luo Q; Fang Y; Su Y; Hu Q; Duan H; Chen F; Zhang ZY
    Biomark Med; 2017 May; 11(5):431-441. PubMed ID: 28621611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An expression of squamous cell carcinoma antigen 2 in peripheral blood within the different stages of esophageal carcinogenesis.
    Yang YF; Li H; Xu XQ; Diao YT; Fang XQ; Wang Y; Zhao DL; Wu K; Li HQ
    Dis Esophagus; 2008; 21(5):395-401. PubMed ID: 19125792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated levels of serum metalloproteinase 9 in patients with esophageal squamous cell carcinoma.
    Łukaszewicz-Zajac M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
    Pol Arch Med Wewn; 2009 Sep; 119(9):558-63. PubMed ID: 19776700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined detection of serum Dickkopf-1 and its autoantibodies to diagnose esophageal squamous cell carcinoma.
    Peng YH; Xu YW; Guo H; Huang LS; Tan HZ; Hong CQ; Li SS; Xu LY; Li EM
    Cancer Med; 2016 Jul; 5(7):1388-96. PubMed ID: 26988995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-367 is a potential diagnostic biomarker for patients with esophageal squamous cell carcinoma.
    Sun J; Song K; Feng X; Gao S
    Biochem Biophys Res Commun; 2016 Apr; 473(2):363-9. PubMed ID: 26777997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoantibodies against tumor-associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma.
    Sun G; Ye H; Wang X; Li T; Jiang D; Qiu C; Dai L; Shi J; Wang K; Song C; Wang P; Zhang J
    Cancer Med; 2020 Feb; 9(3):1173-1182. PubMed ID: 31856412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of serum melanoma-associated antigen D4 in patients with squamous cell carcinoma of the esophagus.
    Oya H; Kanda M; Koike M; Iwata N; Niwa Y; Shimizu D; Takami H; Sueoka S; Hashimoto R; Ezaka K; Nomoto S; Yamada S; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Kodera Y
    Dis Esophagus; 2016 Aug; 29(6):663-9. PubMed ID: 25951896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Significance of CEA, SCC and Cyfra21-1 serum test in esophageal cancer].
    Mao YS; Zhang DC; Zhao XH; Wang LJ; Qi J; Li XX
    Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):457-60. PubMed ID: 14575569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chitinase 3-like 1 secreted by peritumoral macrophages in esophageal squamous cell carcinoma is a favorable prognostic factor for survival.
    Xing S; Zheng X; Zeng T; Zeng MS; Zhong Q; Cao YS; Pan KL; Wei C; Hou F; Liu WL
    World J Gastroenterol; 2017 Nov; 23(43):7693-7704. PubMed ID: 29209110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
    Guan S; Wang C; Chen X; Liu B; Tan B; Liu F; Wang D; Han L; Wang L; Huang X; Wang J; Yao B; Shi J; Chen P; Nesa EU; Song Q; Cheng Y
    Tumour Biol; 2016 Apr; 37(4):4383-91. PubMed ID: 26499784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum HOTAIR as a novel diagnostic biomarker for esophageal squamous cell carcinoma.
    Wang W; He X; Zheng Z; Ma X; Hu X; Wu D; Wang M
    Mol Cancer; 2017 Apr; 16(1):75. PubMed ID: 28376832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accuracy of surveillance serum squamous cell carcinoma antigen for cervical cancer recurrence after definitive chemoradiation.
    Shi V; Grover S; Huang Y; Thaker PH; Kuroki LM; Powell MA; Mutch DG; Contreras JA; Schwarz JK; Grigsby PW; Markovina S
    Int J Gynecol Cancer; 2024 Jun; 34(6):808-816. PubMed ID: 38684343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum SCCA, Cyfra 21-1, EGFR and Cyclin D1 levels in patients with oral squamous cell carcinoma.
    Feng XY; Li JH; Li JZ; Han ZX; Xing RD
    Int J Biol Markers; 2010; 25(2):93-8. PubMed ID: 20586028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Value of the concentration and integrity of serum cell-free DNA for the clinical diagnosis of esophageal carcinoma].
    Qiu YW; Shen XJ; Jin CJ; Cao XJ; Ju SQ
    Zhonghua Zhong Liu Za Zhi; 2018 Dec; 40(12):905-910. PubMed ID: 30605980
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical significance of serum macrophage-colony stimulating factor (M-CSF) in esophageal cancer patients and its comparison with classical tumor markers.
    Łukaszewicz-Zajac M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
    Clin Chem Lab Med; 2010 Oct; 48(10):1467-73. PubMed ID: 20604722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CYFRA21-1 and CEA are useful markers for predicting the sensitivity to chemoradiotherapy of esophageal squamous cell carcinoma.
    Yi Y; Li B; Wang Z; Sun H; Gong H; Zhang Z
    Biomarkers; 2009 Nov; 14(7):480-5. PubMed ID: 19863186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Squamous Cellular Carcinoma Antigen Serum Determination as a Biomarker of Barrett Esophagus and Esophageal Cancer: A Phase III Study.
    Maddalo G; Fassan M; Cardin R; Piciocchi M; Marafatto F; Rugge M; Zaninotto G; Pozzan C; Castoro C; Ruol A; Biasiolo A; Farinati F
    J Clin Gastroenterol; 2018; 52(5):401-406. PubMed ID: 28422774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.